Australia's underwhelming 93rd rank on the Harvard Economic Complexity Index (ECI) reveals a pressing need for economic diversification.
With an over-reliance on agriculture and mining, we rank lowest among Organisation for Economic Co-operation and Development (OECD) nations.
Under-investment in biotech
Despite abundant natural resources, experts say the failure to invest in sunrise industries, like biotechnology, which contributes an annual revenue of just A$8 billion to the economy, could jeopardise Australia's long-term economic sustainability.
Encouragingly, government initiatives like National Science Week are fostering scientific innovation, identifying industries that can elevate Australia's economic complexity.
The National Health and Medical Research Council (NHMRC)-funded biomedical research has also placed Australia at the 10th position globally for research output, according to the prestigious Nature rankings.
The A$20 billion Medical Research Future Fund (MRFF) aims to transition this top-tier research into life-saving drugs and therapies.
The biotech sector is not just a field of innovation but a critical pillar for Australia's economic future.
It offers resilience against global economic volatility and creates opportunities for high-skilled employment. The time is ripe for leveraging Australia's current wealth to invest substantially in biotechnology, a sunrise industry with immense promise.
There are signs that the sector is opening up, post-pandemic – and not just because of the interest brought by the innovations that COVID-19 compelled corporations to deliver.
Careers in the sector
The pathway to a career in biotech is more assured, post-pandemic. While the COVID-19 years propelled virtual job fairs to the forefront, offering cost-effective, safe and wide-reaching platforms for both employers and prospective employees, these fairs are making a welcome return to the physical world.
Students and experts alike emphasise the irreplaceable value of in-person interactions for networking and gauging company culture.
This trend underlines a distinct difference between early talent and experienced professionals; the former find immense value in face-to-face interactions, reflecting a nuanced approach to recruitment in the biotech sector.
These shifts in recruitment strategies offer a comprehensive view of the biotech industry's adaptability and its commitment to attracting highly skilled talent, further solidifying its role as a critical pillar for Australia's economic future.
Besides direct interaction with recruiters, in-person events offer a platform for meaningful engagement with peers and alumni and serve as information hubs, allowing students to explore employers graduates had perhaps not considered before.